The board of directors of AbbVie Inc (NYSE:ABBV) declared on Thursday its quarterly dividend of USD0.96 per share of its stock.
This cash dividend will be paid on 15 August 2018 to stockholders of record at the close of business as of 13 July 2018.
Since the company's inception in 2013, the company has raised its dividend by 140%.
According to the research-driven biopharmaceutical company, it is committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. In more than 75 countries, its employees are working every day to advance health solutions for people around the world.
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline